Discontinuation report CEFTIN - TAB 250MG
| Report ID | 121046 |
| Drug Identification Number | 02212277 |
| Brand name | CEFTIN - TAB 250MG |
| Common or Proper name | Cefuroxime axetil tablet |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CEFUROXIME |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | All pack sizes / Tous les formats |
| ATC code | J01DC |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-07-20 |
| Remaining supply date | 2019-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-07-24 | French | Compare |
| v7 | 2020-07-24 | English | Compare |
| v6 | 2020-07-24 | French | Compare |
| v5 | 2020-07-24 | English | Compare |
| v4 | 2020-07-24 | French | Compare |
| v3 | 2020-07-24 | English | Compare |
| v2 | 2020-07-24 | French | Compare |
| v1 | 2020-07-24 | English | Compare |
Showing 1 to 8 of 8